Integrating health-related quality of life findings from randomized clinical trials into practice: an international study of oncologists’ perspectives

Quality of Life Research

Volumn 24, Issue 6, 2015, Pages 1317-1325

  Rouette, Julie ^a,b   Blazeby, Jane ^c   King, Madeleine ^d   Calvert, Melanie ^e   Peng, Yingwei ^a,b   Meyer, Ralph M ^f   Ringash, Jolie ^g   Walker, Melanie ^a   Brundage, Michael D ^a,b  

^a QUEEN S UNIVERSITY   (Canada)

^b QUEEN S UNIVERSITY   (Canada)

^c UNIVERSITY OF BRISTOL   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

^e UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^f MCMASTER UNIVERSITY   (Canada)

^g UNIVERSITY OF TORONTO   (Canada)

Author keywords

Cancers; Cross sectional surveys; Patient reported outcomes; Phase III clinical trials; Quality of life; Randomized controlled trials

Indexed keywords

ATTITUDE TO HEALTH; AUSTRALIA; CLINICAL DECISION MAKING; CROSS-SECTIONAL STUDY; FEMALE; HUMAN; MALE; MEDICAL RESEARCH; NEOPLASMS; NEW ZEALAND; PHYSICIAN; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL (TOPIC); TIME; UNITED KINGDOM;

AUSTRALIA; BIOMEDICAL RESEARCH; CLINICAL DECISION-MAKING; CROSS-SECTIONAL STUDIES; FEMALE; GREAT BRITAIN; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; NEOPLASMS; NEW ZEALAND; PHYSICIANS; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SURVEYS AND QUESTIONNAIRES; TIME;

EID: 84930479942     PISSN: 09629343     EISSN: 15732649     Source Type: Journal    
DOI: 10.1007/s11136-014-0871-9     Document Type: Article

References (31)

1. Osoba, D. (2011). Health-Related Quality of Life and cancer clinical trials. Therapeutic Advances in Medical Oncology,3, 57–71.
2. Bezjak, A., Ng, P., Skeel, R., et al. (2001). Oncologists’ use of quality of life information: Results of a survey of eastern cooperative oncology group physicians. Quality of Life Research,10, 1–13.
3. Guyatt, G. H., Ferrans, C. E., Halyard, M. Y., et al. (2007). Exploration of the value of health-related quality-of-life information from clinical research and into clinical practice. Mayo Clinic Proceedings,82, 1229–1239.
4. Greenhalgh, J. (2009). The applications of PROs in clinical practice: What are they, do they work, and why? Quality of Life Research,18, 115–123.
5. Basch, E. (2010). The missing voice of patients in drug-safety reporting. New England Journal of Medicine,362, 865–869.
6. Au, H.-J., Ringash, J., Brundage, M., et al. (2010). Added value of Health-Related Quality of Life measurement in cancer clinical trials: The experience of the NCIC CTG. Expert Review of Pharmacoeconomics & Outcomes Research,10, 119–128.
7. Brundage, M., & Snyder, C. (2012). Patient-reported outcomes in clinical practice: Using standards to break down barriers. Clinical Investigation,2, 343–346.
8. Brundage, M., Bass, B., Jolie, R., et al. (2011). A knowledge translation challenge: Clinical use of quality of life data from cancer clinical trials. Quality of Life Research,20, 979–985.
9. Brundage, M., Bass, B., Davidson, J., et al. (2011). Patterns of reporting Health-Related Quality of Life outcomes in randomized clinical trials: Implications for clinicians and quality of life researchers. Quality of Life Research,20, 653–664.
10. Meldahl, M. L., Acaster, S., & Hayes, R. P. (2013). Exploration of oncologists’ attitudes toward and perceived value of patient-reported outcomes. Quality of Life Research,22, 725–731.
11. Calvert, M., Blazeby, J., Revicki, D., et al. (2011). Reporting quality of life in clinical trials: A CONSORT extension. Lancet,378, 1684–1685.
12. Sackett, D. (1991). How to get the most from and give the most to continuing medical education. In B. Haynes, D. Sackett, G. Guyatt & P. Tugwell (Eds.), Clinical epidemiology: A basic science for clinical medicine, 2nd ed. Boston/Toronto: Little, Brown and Co.
13. Logan, J., & Graham, I. D. (1998). Toward a comprehensive interdisciplinary model of health care research use. Science Communication,20, 227–246.
14. Dillman, D. A. (2000). Mail and internet surveys- the tailored design method. New York, NY: Wiley.
15. SurveyMonkey Inc: www.surveymonkey.com.
16. Gough, I., & Dalgleish, L. (1991). What value is given to quality of life by health professionals considering response to palliative chemotherapy for advanced cancer? Cancer,68, 220–225.
17. Bezjak, A., Taylor, K. M., Ng, P., et al. (1998). Quality-of-life information and clinical practice: the oncologist’s perspective. Cancer Prevention & Control,2, 230–235.
18. Walsh, D. L., & Emrich, L. J. (1998). Measuring cancer patients’ quality of life: A look at physician attitudes. New York State Journal of Medicine,88, 354–357.
19. Taylor, K. M., Feldstein, M. L., Skeel, R., et al. (1994). Fundamental dilemmas of the randomized clinical trial process: Results of a survey of the 1,737 eastern cooperative oncology group investigators. Journal of Clinical Oncology,12, 1796–1805.
20. Morris, J., Perez, D., & McNoe, B. (1998). The use of quality of life data in clinical practice. Quality of Life Research,7, 85–91.
21. Ringash, J., & Bezjak, A. (2006). Use of quality-of-life assessment for nasopharyngeal cancer. Clinical Oncology (R Coll Radiol),18, 725–727.
22. Goodwin, P. J., Black, J. T., Bordeleau, L. J., et al. (2003). Health-related quality-of-life measurement in randomized clinical trials in breast cancer—taking stock. Journal of the National Cancer Institute,95, 263–281.
23. Efficace, F., Feuerstein, M., Fayers, P., et al. (2014). Patient-reported outcomes in randomised controlled trials of prostate cancer: Methodological quality and impact on clinical decision making. European Urology, 66, 416–427.
24. Guyatt, G., & Schunemann, H. (2007). How can quality of life researchers make their work more useful to health workers and their patients? Quality of Life Research,16, 1097–1105.
25. McNair, A. G., Brookes, S. T., Davis, C. R., et al. (2010). Communicating the results of randomized clinical trials: Do patients understand multidimensional patient-reported outcomes? Journal of Clinical Oncology,28, 738–743.
26. Calvert, M., Blazeby, J., Altman, D. G., et al. (2013). Reporting of patient-reported outcomes in randomized trials: The CONSORT PRO extension. JAMA,309, 814–822.
27. International Society for Quality of Life Research. Best Practices for PROs in Randomized Clinical Trials: http://www.isoqol.org/about-isoqol/committees/best-practices-for-pros-in-randomized-clinical-trials.
28. Brundage, M., Blazeby, J., Revicki, D., et al. (2013). Patient-reported outcomes in randomized clinical trials: Development of ISOQOL reporting standards. Quality of Life Research,22, 1161–1175.
29. Kyte, D., Duffy, H., Fletcher, B., et al. (2014). Systematic evaluation of the patient-reported outcome (PRO) content of clinical trial protocols. PLoS One,9(10), e110229. doi:10.1371/journal.pone.0110229.
30. Calvert, M., Brundage, M., Jacobsen, P. B., et al. (2013). The CONSORT patient-reported outcome (PRO) extension: Implications for clinical trials and practice. Health and Quality of Life Outcomes,11, 184.
31. Calvert, M., Kyte, D., Duffy, H., et al. (2013). Patient-reported outcome (PRO) assessment in clinical trials: A systematic review of guidance for trial protocol writers. PLoS One,9(10), e110216. doi:10.1371/journal.pone.0110216.